3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neuroblastoma
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lung Neoplasms
3
Leukemia, Myelomonocytic, Juvenile
3
Head and Neck Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Recurrence
2
Neoplasms
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Medulloblastoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
HIV Infections
2
Ganglioneuroblastoma
2
Central Nervous System Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Brain Neoplasms
2
Acquired Immunodeficiency Syndrome
2
AIDS-Related Complex
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Tumor Virus Infections
1
Thrombocytopenia
1
Interventions
Amifostine
12
Cisplatin
10
Radiotherapy
8
Etoposide
8
Cyclophosphamide
5
Paclitaxel
4
Filgrastim
4
Gemcitabine
3
Cytarabine
3
Carboplatin
3
denileukin diftitox
2
apatinib
2
Vincristine
2
Pyridoxine
2
Irinotecan
2
Ifosfamide
2
Fibroblast Growth Factor 7
2
Epoetin Alfa
2
Doxorubicin
2
Dexamethasone
2
Chemotherapy, Adjuvant
2
Bleomycin
2
uridine triacetate
1
sargramostim
1
peginterferon alfa-2b
1
pegfilgrastim
1
pegaspargase
1
eribulin
1
camrelizumab
1
Vitamin E
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Drug-Related Side Effects and Adverse Reactions
×
Isotretinoin
×
Clear all
NCT00002586
2020-05-15
13-Cis
University of Colorado, Denver
Phase 2
Completed
96 enrolled